{
  "id": 12636477,
  "title": "Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s",
  "url": "https://urgent.news/2026/10/07/drug-target-could-block-brain-inflammation-linked-to-alzheimers-and-12636477",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-07T12:13:35.000Z",
  "source": {
    "name": "ScienceDaily",
    "slug": "sciencedaily",
    "url": "https://www.sciencedaily.com/releases/2026/10/261005071515.htm"
  },
  "original_language": "en",
  "account": null,
  "summary": "Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "A Takeda spinout builds case for its Parkinson’s drug",
        "url": "https://urgent.news/2026/10/07/a-takeda-spinout-builds-case-for-its-parkinsons-drug",
        "published": "2026-10-07T12:01:00.000Z"
      },
      {
        "outlet": "ScienceDaily Health",
        "title": "Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s",
        "url": "https://urgent.news/2026/10/07/drug-target-could-block-brain-inflammation-linked-to-alzheimers-and",
        "published": "2026-10-07T12:13:35.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}